$2.4 Billion Allergy Immunotherapies Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 - ResearchAndMarkets.com

DUBLIN--()--The "Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global allergy immunotherapies market was worth US$ 1.6 Billion in 2018

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen.

Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world.

Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Looking forward, the market to reach a value of US$ 2.4 Billion by 2024, registering a CAGR of around 7% during 2019-2024.

Key Questions Answered in This Report:

  • How has the global allergy immunotherapies market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global allergy immunotherapies industry?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the allergy type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the global allergy immunotherapies industry?
  • What are the key driving factors and challenges in the global allergy immunotherapies industry?
  • What is the structure of the global allergy immunotherapies industry and who are the key players?
  • What is the degree of competition in the global allergy immunotherapies industry?
  • What are the profit margins in the global allergy immunotherapies industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Treatment Type

5.4 Market Breakup by Allergy Type

5.5 Market Breakup by Distribution Channel

5.6 Market Breakup by Region

5.7 Market Forecast

6 Market Breakup by Treatment Type

6.1 Subcutaneous Immunotherapy (SCIT)

6.2 Sublingual Immunotherapy (SLIT)

7 Market Breakup by Allergy Type

7.1 Allergic Rhinitis

7.2 Asthma

7.3 Food Allergy

7.4 Venom Allergy

7.5 Others

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacy

8.2 Retail Pharmacy

8.3 Online Pharmacy

9 Market Breakup by Region

10 SWOT Analysis

10.1 Overview

10.2 Strengths

10.3 Weaknesses

10.4 Opportunities

10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview

12.2 Bargaining Power of Buyers

12.3 Bargaining Power of Suppliers

12.4 Degree of Competition

12.5 Threat of New Entrants

12.6 Threat of Substitutes

13 Price Analysis

13.1 Price Indicators

13.2 Price Structure

13.3 Margin Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

14.3.1 ALK-Abello A/S

14.3.2 Allergy Therapeutics

14.3.3 Stallergenes Greer

14.3.4 HAL Allergy Group

14.3.5 DBV Technologies

14.3.6 Merck Group

14.3.7 Aimmune Therapeutics

14.3.8 Circassia Pharmaceuticals

14.3.9 Anergis SA

14.3.10 Biomay AG

For more information about this report visit https://www.researchandmarkets.com/r/n5jli4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900